BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1503487)

  • 1. [Effects of UFT and loxiglumide (CR1505) on liver metastasis of human pancreatic cancer cell line, KP-1 N in nude mice].
    Shimazoe T; Funakoshi A; Kono A
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1321-5. PubMed ID: 1503487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loxiglumide (CR1505), a cholecystokinin antagonist, specifically inhibits the growth of human pancreatic cancer lines xenografted into nude mice.
    Nio Y; Tsubono M; Morimoto H; Kawabata K; Masai Y; Hayashi H; Manabe T; Imamura M; Fukumoto M
    Cancer; 1993 Dec; 72(12):3599-606. PubMed ID: 8252474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of combined use of CR1505 with UFT for the tumor growth of the subcutaneously transplanted pancreatic cancer in the Syrian golden hamsters].
    Tomioka M; Miyazaki N; Yamamoto M; Saito Y
    Nihon Shokakibyo Gakkai Zasshi; 1993 Mar; 90(3):693-9. PubMed ID: 8515583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiproliferative and antimetastatic effects of UFT on MKL-4 human breast cancer cells transplanted into nude mice].
    Kurebayashi J; Sonoo H
    Gan To Kagaku Ryoho; 1995 Apr; 22(5):665-70. PubMed ID: 7717719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition of human pancreatic cancer cells by cholecystokinin receptor antagonist in tissue culture and in nude mice.
    Funakoshi A; Kono A
    Gastroenterol Jpn; 1992 Feb; 27(1):78-82. PubMed ID: 1555749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholecystokinin antagonistic activities of loxiglumide.
    Wakatsuki K; Saito T; Saeki M; Ninomiya K; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1997 Oct; 47(10):1130-3. PubMed ID: 9368707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between antitumor activity and the inhibition of thymidylate synthase after oral administration of UFT in nude mice bearing human tumor].
    Fujita M; Fujita F; Uchida J; Takeda S; Yamada Y; Taguchi T
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):627-32. PubMed ID: 2108611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of combined use of CR 1505 with UFT on tumor growth of transplanted pancreatic cancer in the Syrian golden hamster: preliminary report].
    Tomioka M; Miyazaki N; Yamamoto M; Saito Y
    Nihon Geka Gakkai Zasshi; 1992 Jan; 93(1):106. PubMed ID: 1549090
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral administration of uracil-tegafur (UFT) inhibits liver micrometastasis of human colon cancer in an orthotopic nude mouse model and its early detection system.
    Takahashi Y; Yamashita K; Endo Y; Sasaki T; Mai M
    Surg Today; 2004; 34(10):855-9. PubMed ID: 15449156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental study of UFT in prostatic carcinoma (DU-145) in nude mice].
    Kagawa S; Takigawa H; Aga Y; Kurokawa K
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3408-12. PubMed ID: 3098182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between the anti-metastatic effect of UFT and in vitro chemosensitivity to 5-FU in metastatic tumors from orthotopic implanted colon cancer in nude rats].
    Ogata Y; Akagi Y; Nozoe Y; Sasatomi T; Miyagi Y; Nakagawa M; Matono K; Kobayashi H; Shirouzu K
    Gan To Kagaku Ryoho; 2001 May; 28(5):655-60. PubMed ID: 11383214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipyridamole augments the antitumor effects of fluorinated pyrimidines.
    Sakaguchi Y; Kusumoto T; Kusumoto H; Maehara Y; Furusawa M; Sugimachi K
    Anticancer Res; 1992; 12(1):119-21. PubMed ID: 1567156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of UFT by oral administration using a murine hepatic metastasis model].
    Yunoki S; Hizuta A; Sou J; Takahashi M; Nagata Y; Yamamoto M; Kataoka K; Matumoto M; Kawaguchi H; Miyagi K
    Gan To Kagaku Ryoho; 1991 Sep; 18(12):2117-20. PubMed ID: 1888182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vivo chemosensitivity test for UFT and FT-207. II. Chemosensitivity test on human tumor xenografts transplanted in nude mice].
    Niimi K; Nishiyama M; Hirabayashi N; Yamaguchi M; Nosoh Y; Wang DC; Toge T; Niimoto M; Hattori T
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1281-5. PubMed ID: 3107479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of CR1505, a CCK antagonist, on pancreatic growth in hamsters].
    Tasi Y; Baba N; Nishimura I; Manabe T; Tobe T
    Nihon Shokakibyo Gakkai Zasshi; 1991 Apr; 88(4):1097-104. PubMed ID: 1857003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A sensitivity test of UFT and FT-207 against human pulmonary cancer using nude mice].
    Urabe N; Momiki S; Shiba M; Yamaguchi Y
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2224-8. PubMed ID: 3136694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postsurgical oral administration of uracil and tegafur inhibits progression of micrometastasis of human breast cancer cells in nude mice.
    Kurebayashi J; Nukatsuka M; Fujioka A; Saito H; Takeda S; Unemi N; Fukumori H; Kurosumi M; Sonoo H; Dickson RB
    Clin Cancer Res; 1997 May; 3(5):653-9. PubMed ID: 9815733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of a cholecystokinin antagonist, loxiglumide (CR-1505), on the growth of freshly separated and xenografted human pancreatic cancer.
    Morimoto H; Nio Y; Tsubono M; Tseng CC; Kawabata K; Masai Y; Hayashi H; Baba N; Manabe T; Hosokawa Y
    J Surg Oncol; 1993 May; 53(1):47-53. PubMed ID: 8386784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antitumor effect of UFT on human ovarian cancer grafted to nude mice and 5-FU concentration in tumor and normal tissues].
    Yoshiya N; Adachi S; Misawa Y; Ishida M; Yuzawa H; Kanazawa K; Takeuchi S
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):285-9. PubMed ID: 3124768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lorglumide and loxiglumide inhibit gastrin-stimulated DNA synthesis in a rat tumoral acinar pancreatic cell line (AR42J).
    Seva C; Scemama JL; BastiƩ MJ; Pradayrol L; Vaysse N
    Cancer Res; 1990 Sep; 50(18):5829-33. PubMed ID: 2393852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.